These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 22081582)
1. Extrafine aerosols and peripheral airway function in asthma. Merkus PJ; Gappa M; Janssens H; Pijnenburg MW Pediatr Pulmonol; 2012 Jun; 47(6):626; author reply 627. PubMed ID: 22081582 [No Abstract] [Full Text] [Related]
2. Lung function changes in asthmatic children treated with HFA-BDP. Eid N; Morton R Pediatr Pulmonol; 2011 Sep; 46(9):837-41. PubMed ID: 21465678 [TBL] [Abstract][Full Text] [Related]
3. [Progress of research on pressurized metered dose inhalers]. Zhou X Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147 [No Abstract] [Full Text] [Related]
4. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808 [TBL] [Abstract][Full Text] [Related]
5. [Bronchial asthma. Small bronchi are not spared]. MMW Fortschr Med; 2002 May; 144(18):64. PubMed ID: 12422715 [No Abstract] [Full Text] [Related]
6. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone. Lipworth BJ; Jackson CM Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427 [No Abstract] [Full Text] [Related]
7. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study. Ederle K; Eur Rev Med Pharmacol Sci; 2003; 7(2):45-55. PubMed ID: 12911119 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children. van Schayck CP; Donnell D Int J Clin Pract; 2004 Aug; 58(8):786-94. PubMed ID: 15372852 [TBL] [Abstract][Full Text] [Related]
9. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. Micheletto C; Guerriero M; Tognella S; Dal Negro RW Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246 [TBL] [Abstract][Full Text] [Related]
10. Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma. Nicolini G; Chetta A; Simonazzi A; Tzani P; Aiello M; Olivieri D Allergy Asthma Proc; 2010; 31(5):85-90. PubMed ID: 20929599 [TBL] [Abstract][Full Text] [Related]
11. Targeting drug delivery and the small airways in asthma. Williams A Hosp Med; 1998 Jun; 59(6):488-91. PubMed ID: 9775278 [TBL] [Abstract][Full Text] [Related]
12. Qvar for Treatment of Chronic Asthma. Jayanth A Am Fam Physician; 2018 Apr; 97(8):538-539. PubMed ID: 29671500 [No Abstract] [Full Text] [Related]
13. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients. Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204 [TBL] [Abstract][Full Text] [Related]
20. Part III: Location of asthma inflammation and the distal airways: clinical implications. Kraft M Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S21-7. PubMed ID: 17925065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]